A. Lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis were linked to reduced risks of most micro- and macrovascular complications in the UKPDS 61 cohort, indicating improved outcomes for these patients [Colagiuri et al., 2002, PMID 12145243].